EGFR-HER2 inhibitor BIBX 1382, Purity ≥98%

Cat. No.: X23-10-ZQ1057

EGFR-HER2 inhibitor BIBX 1382, Purity ≥98%

Synonym: Falnidamol; 196612-93-8; BIBX 1382; BIBX1382; BIBX-1382; N8-(3-Chloro-4-fluorophenyl)-N2-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-2,8-diamine; EGFR-HER2 inhibitor

  • MDL: MFCD09838900
  • CAS Number: 196612-93-8
  • Compound CID: 6918508
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
BIBX 1382 is a potent and specific inhibitor of the tyrosine kinase activity of EGFR. It targets EGFR and ErbB2.
Molecular Weight
460.8
Molecular Formula
C18H19ClFN7.2HCl
Targets
EGFR: 3 nM; ErbB2: 3.4 μM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
BIBX 1382 can be used to inhibit EGFR tyrosine kinase for research into cancer therapy.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0